There are several controversial studies on circulating sfrp5 concentration in obesity and type 2 diabetes patients14-17 as well as on animal experiments.18,19 However there is no such report including patients of LADA to our knowledge. Here, SFRP5 is linked to obesity due to melanocortin 4 receptor deficiency.